Latest Asx News

Simble Solutions edges closer to $1 million in annual recurring revenue as major customer rollouts advance and its NanoSensor program moves forward along a structured development pathway.

MB Gold has reported further encouraging gold assay results from its maiden drilling at the Twin Veins Prospect, confirming continuity of high-grade shoots and setting the stage for a 6,000m Phase 2 program.

Jindalee Lithium Limited’s JLLOB securities have been suspended from trading under ASX rules, reflecting unresolved compliance issues. The suspension affects only this security class, leaving other company shares unaffected.

X2M Connect has unveiled a new AI-enabled bidirectional streetlight controller in South Korea, expanding its smart city platform and tapping into a $225 million annual market.

Medallion Metals has identified a significant new sulphide lode, Hillsborough Deeps, beneath the Gem deposit at Kundip, with drilling and electromagnetic surveys indicating strong potential for resource expansion.

ABx Group and Good Importing International are progressing their bauxite projects in Queensland and New South Wales, with environmental approvals on track and significant investments underway.

Perseus Mining has boosted its on-market share buy-back program by A$50 million to A$150 million, reflecting confidence in its balance sheet and cash flow generation while maintaining funding for organic growth.

Great Southern Mining (ASX: GSN) is embarking on its largest drilling campaign to date at its Western Australian gold projects, aiming to extend mineralisation at Golden Boulder, Amy Clarke, and Mon Ami. Recent diamond drilling has revealed deeper gold potential, underpinning the aggressive program.

Environmental Clean Technologies (ASX: ECT) has completed a pilot Rapid Electrothermal Mineralisation system that delivers 18 times the power of its lab prototype, enabling additive-free, in-situ PFAS destruction and targeting a field demonstration in H2 2026.

TG Metals has expanded the Van Uden gold resource by 1.8km to a total strike of 4.3km, revealing significant high-grade gold intercepts and advancing a near-term heap leach opportunity supported by promising laterite drilling.

EDU Holdings lifted total student enrolments by 32% in Trimester 2 2026, driven by strong growth at its higher education arm Ikon Institute, offsetting softness in its vocational training division.

Paradigm Biopharmaceuticals has completed enrolment ahead of schedule in its pivotal Phase 3 trial for Zilosul®, enrolling 538 patients with knee osteoarthritis and maintaining its timeline for interim and final results.